Bell Potter Sticks to Their Buy Rating for Telix Pharmaceuticals (TLPPF)
I'm PortAI, I can summarize articles.
According to TipRanks, Hester is a 4-star analyst with an average return of 11.8% and a 55.56% success rate. Hester covers the Healthcare sector, focusing on stocks such as Telix Pharmaceuticals, Sigma Healthcare Ltd, and Mesoblast Limited. In addition to Bell Potter, Telix Pharmaceuticals also received a Buy from Morgan Stanley’s David Bailey in a report issued on September 23. However, on September 24, TR | OpenAI – 4o reiterated a Hold rating on Telix Pharmaceuticals (Other OTC: TLPPF).
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments